(YFP-RyR1 1:4300 ), which encodes the cytoplasmic domain of RyR1 ("foot") but lacks the C-terminal domains which form the ion pore for SR calcium release and which anchor RyR1 in the SR membrane. We found that YFPRyR1 1:4300 targets to PM-SR junctions in dyspedic myotubes (null for endogenous RyR1) and transmits the retrograde signal to the DHPRs present in those myotubes. We have now begun to examine whether these interactions between the RyR1 foot and DHPR can occur in the absence of other proteins which are present in PM-SR junctions of muscle cells. Toward this end, we used tsA201 cells to co-express CFP-RyR1 1:4300 , YFP-Ca V 1.1 (or Ca V 1.1/Ca V 1.2 chimeras) and the DHPR auxiliary subunit b1a. Most of the Ca V constructs appeared to be retained in a peri-nuculear compartment (Ca V 1.1, and chimeras in which three Ca V 1.1 repeats were replaced by the corresponding Ca V 1.2 repeats). PMtargeting was observed for a construct composed of Ca V 1.2 with the cytoplasmic II-III loop replaced by that of Ca V 1.1. However, we have not yet observed co-localization of CFP-RyR1 1:4300 with any of the Ca V constructs. We are currently testing whether the presence of additional, junctional proteins will result in co-localization of RyR1 1:4300 and Ca V . Supported by grants NIH AR055104 and MDA 277475 to K.G.B. current and/or membrane-bound charge movement. However, simultaneous replacement of all four Ca V 1.1 repeats with those of Ca V 1.2, while retaining Ca V 1.1 sequence for the cytoplasmic domains (construct ''CSk9''), resulted in increased expression, although not to the level of Ca V 1.2. By contrast, expression levels of CSk9 and Ca V 1.2 were equivalent in dysgenic myotubes. Thus, both the transmembrane and cytoplasmic domains appear to play a role in suppressing expression of Ca V 1.1 in nonmuscle cells. To investigate which cytoplasmic domains might be particularly important at suppressing expression, we tested Ca V 1.2 constructs in which the I-II loop, II-III loop, I-II and II-III loops, or C-terminus were replaced with Ca V 1.1 sequence and found expression not to differ for any of these constructs from that of the entirely Ca V 1.2 construct. We are currently testing constructs of Ca V 1.2 with other combinations of cytoplasmic domains replaced by Ca V 1.1. Following membrane depolarization S4 segments of voltage-gated cation channels translocate through the membrane resulting in the opening of the channel pore. This mechanism has been extensively studied in potassium and sodium channels yet little is known about it in voltage-gated calcium channels. Here we used de-novo ROSETTA modelling and site-directed mutagenesis to study the transition of the IV th voltage-sensing-domain (VSD) of Cav1.1 calcium channel during gating. Previously we have shown that the embryonic Cav1.1e splice variant, lacking exon 29 in the IVS3-S4 linker, has an 8-fold higher current amplitude and 30mV left-shifted voltage-sensitivity compared to the adult Cav1.1a splice variant. Modeling 4 consecutive states of the VSD suggested that the number of H-bonds formed between the arginines of IVS4 and residues in IVS3 is higher in Cav1.1e than in Cav1.1a. Among them aspartate at position 1196 (D1196) shows the strongest difference between the two splice variants. Indeed, voltage clamp recordings show that neutralizing the negative charge in S3 (D1196N) has no effect on the voltage sensitivity of Cav1.1a but confers poor voltage sensitivity to Cav1.1e. Mutations of R1210, R1217, and R1220 of Cav1.1e are currently analyzed to identify the interaction partners of D1196 during gating. Furthermore, structure modeling revealed an extracellularly exposed hydrophobic cluster formed by two leucines in the middle of IVS3-S4 loop encoded by exon 29. Point mutations which eliminate this hydrophobic cluster partially recapitulate the effects of exon 29 deletion. Together these findings suggest a model according to which the extracellular loop S3-S4 controls the orientation of S3 and S4 relative to each other. This alters charge compensation of positive charges in S4 and dramatically reduces the voltage sensitivity of CaV1.1a calcium channels. Support: FWF W1101, P23479, LFU-P7400-027-011. (Campiglio et al., JCS 2013). To further test the reversibility of the Ca V 1.2/b 2a interaction, here we injected an AID peptide into Xenopus oocytes expressing Ca V 1.2/b 2a /a 2 d-1 complexes and examined the effect of the competing peptide on current inactivation. Unexpectedly, the AID peptide had no effect on the currents of wildtype Ca V 1.2/ b 2a /a 2 d-1 channel complexes. However, when a Ca V 1.2 AID residue known to decrease the interaction with b 2a by 1000-fold was mutated (Y437A), injection of AID peptide changed the inactivation properties of the channels similar to properties of channels expressed without a b subunit. These results suggest that under our experimental conditions binding of the wild-type Ca V 1.2/b 2a pair is too strong for peptide competition. In contrast, in wild-type Ca V 1.2 channel complexes containing the b 3 subunit injection of the AID peptide caused a strong effect on inactivation properties, indicating efficient competition. Consistent with a lower stability of Ca V 1.2/b 3 complexes compared to Ca V 1.2/b 2a , b 3 also showed a significantly reduced extent of co-clustering with Ca V 1.2 in the triads of dysgenic myotubes. Ongoing FRAP experiments will reveal whether diminished co-clustering of b 3 correlates with higher mobility and dynamic b subunit exchange in a native calcium channel signaling complex. Funding: FWF P23479 and W1101 (BEF), NIH R01 HL080050 (DLM). Klinikum der Universität zu Köln, Koln, Germany. Work in heterologous systems has revealed that RGK (Rad, Rem, Rem2, Gem/Kir) proteins inhibit L-type Ca 2þ channels via three mechanisms: 1) reduction of membrane expression, 2) immobilization of the voltagesensors, and 3) reduction of P o without impaired voltage-sensor movement. However, the question of which of these modes is (are) critical for inhibition of L-type channels in their native environments persists. To address this conundrum in skeletal muscle, we overexpressed Rad and Rem in mouse flexor digitorum brevis (FDB) fibers via in vivo electroporation and examined the abilities of these two RGK isoforms to modulate the L-channel (Ca V 1.1). We found that Rad and Rem both potently inhibit excitation-contraction coupling and L-type current in FDB fibers. Charge movement was reduced (~35%) in fibers overexpressing Rad, but charge movement in Remexpressing fibers was identical to charge movement observed in control fibers. This unexpected result indicated that Rem supports inhibition solely through a mechanism which allows for translocation of Ca V 1.1's voltage-sensors whereas Rad utilizes at least one mode that limits voltage-sensor movement. Since Rad and Rem differ significantly only in their amino-termini, we constructed chimeras to probe the basis for the distinct specificities of Rad-and Rem-mediated inhibition. A chimera composed of the Rem amino-terminus and the Rad core/carboxyl-terminus inhibited L-current without reducing charge movement. Conversely, a chimera having the Rad amino-terminus 136a Sunday, February 16, 2014 
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Physiology and Biophysics, University of Colorado, Denver, Aurora, CO, USA, 2 Tokyo Medical and Dental University, Tokyo, Japan. Compared to the cardiac Ca V 1.2, the skeletal Ca V 1.1 Ca 2þ channel has been very difficult to express in non-muscle cells. To identify domains of Ca V 1.1 that inhibit such expression, we have co-transfected tsA201 cells with b 1a and chimeric constructs of Ca V 1.1 and Ca V 1.2 tagged with YFP. A tandem construct of Ca V 1.1 linked to Ca V 1.2 expressed robustly in tsA201 cells, suggesting that either Ca V 1.2 masks a sequence of Ca V 1.1 which causes ER retention in non-muscle cells, or that Ca V 1.1 lacks a signal important for ER export. Replacement of individual transmembrane repeats of Ca V 1.1 (in non-tandem constructs) with the corresponding repeat of Ca V 1.2 was ineffective at increasing functional expression as indicated by slowly activating, L-type Ca 2þ current and/or membrane-bound charge movement. However, simultaneous replacement of all four Ca V 1.1 repeats with those of Ca V 1.2, while retaining Ca V 1.1 sequence for the cytoplasmic domains (construct ''CSk9''), resulted in increased expression, although not to the level of Ca V 1.2. By contrast, expression levels of CSk9 and Ca V 1.2 were equivalent in dysgenic myotubes. Thus, both the transmembrane and cytoplasmic domains appear to play a role in suppressing expression of Ca V 1.1 in nonmuscle cells. To investigate which cytoplasmic domains might be particularly important at suppressing expression, we tested Ca V 1.2 constructs in which the I-II loop, II-III loop, I-II and II-III loops, or C-terminus were replaced with Ca V 1.1 sequence and found expression not to differ for any of these constructs from that of the entirely Ca V 1.2 construct. We are currently testing constructs of Ca V 1.2 with other combinations of cytoplasmic domains replaced by Ca V 1.1. Following membrane depolarization S4 segments of voltage-gated cation channels translocate through the membrane resulting in the opening of the channel pore. This mechanism has been extensively studied in potassium and sodium channels yet little is known about it in voltage-gated calcium channels. Here we used de-novo ROSETTA modelling and site-directed mutagenesis to study the transition of the IV th voltage-sensing-domain (VSD) of Cav1.1 calcium channel during gating. Previously we have shown that the embryonic Cav1.1e splice variant, lacking exon 29 in the IVS3-S4 linker, has an 8-fold higher current amplitude and 30mV left-shifted voltage-sensitivity compared to the adult Cav1.1a splice variant. Modeling 4 consecutive states of the VSD suggested that the number of H-bonds formed between the arginines of IVS4 and residues in IVS3 is higher in Cav1.1e than in Cav1.1a. Among them aspartate at position 1196 (D1196) shows the strongest difference between the two splice variants. Indeed, voltage clamp recordings show that neutralizing the negative charge in S3 (D1196N) has no effect on the voltage sensitivity of Cav1.1a but confers poor voltage sensitivity to Cav1.1e. Mutations of R1210, R1217, and R1220 of Cav1.1e are currently analyzed to identify the interaction partners of D1196 during gating. Furthermore, structure modeling revealed an extracellularly exposed hydrophobic cluster formed by two leucines in the middle of IVS3-S4 loop encoded by exon 29. Point mutations which eliminate this hydrophobic cluster partially recapitulate the effects of exon 29 deletion. Together these findings suggest a model according to which the extracellular loop S3-S4 controls the orientation of S3 and S4 relative to each other. This alters charge compensation of positive charges in S4 and dramatically reduces the voltage sensitivity of CaV1.1a calcium channels. Support: FWF W1101, P23479, LFU-P7400-027-011. In voltage-gated calcium channels, auxiliary Ca V b subunits function in membrane targeting of the channel and modulation of its gating properties. Structural studies have revealed that the high affinity Ca V a 1 /b interaction relies on a conserved Ca V b-binding sequence in the I-II loop of the Ca V a 1 subunit, called the a-interaction domain (AID). We have previously shown that in skeletal muscle triads the b 1a subunit forms stable complexes with both Ca V 1.1 and Ca V 1.2, while b 2a forms dynamic complexes (Campiglio et al., JCS 2013) . To further test the reversibility of the Ca V 1.2/b 2a interaction, here we injected an AID peptide into Xenopus oocytes expressing Ca V 1.2/b 2a /a 2 d-1 complexes and examined the effect of the competing peptide on current inactivation. Unexpectedly, the AID peptide had no effect on the currents of wildtype Ca V 1.2/ b 2a /a 2 d-1 channel complexes. However, when a Ca V 1.2 AID residue known to decrease the interaction with b 2a by 1000-fold was mutated (Y437A), injection of AID peptide changed the inactivation properties of the channels similar to properties of channels expressed without a b subunit. These results suggest that under our experimental conditions binding of the wild-type Ca V 1.2/b 2a pair is too strong for peptide competition. In contrast, in wild-type Ca V 1.2 channel complexes containing the b 3 subunit injection of the AID peptide caused a strong effect on inactivation properties, indicating efficient competition. Consistent with a lower stability of Ca V 1.2/b 3 complexes compared to Ca V 1.2/b 2a , b 3 also showed a significantly reduced extent of co-clustering with Ca V 1.2 in the triads of dysgenic myotubes. Ongoing FRAP experiments will reveal whether diminished co-clustering of b 3 correlates with higher mobility and dynamic b subunit exchange in a native calcium channel signaling complex. Funding: FWF P23479 and W1101 (BEF), NIH R01 HL080050 (DLM). 
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